title: Diagnosis and management of Barrett's esophagus.
abstract: Barrett esophagus is characterized by the replacement of squamous mucosa in the esophagus by specialized intestinal metaplasia. Its clinical significance lies in it being the strongest risk factor for and known precursor for esophageal adenocarcinoma. Diagnosis requires endoscopic confirmation of columnar metaplasia in the distal esophagus and histologic confirmation of specialized intestinal metaplasia. Recommendations for the management of subjects diagnosed with Barrett esophagus include periodic endoscopic surveillance to detect the development of high-grade dysplasia or adenocarcinoma. Careful endoscopic evaluation with high-resolution endoscopy and endoscopic resection is recommended in the evaluation of subjects with high-grade dysplasia and early adenocarcinoma.
authors.affiliation: Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: Eric M
authors.initials: EM
authors.lastname: Nelsen
authors.forename: Robert H
authors.initials: RH
authors.lastname: Hawes
authors.forename: Prasad G
authors.initials: PG
authors.lastname: Iyer
mesh_terms: D055011:Ablation Techniques; D001471:Barrett Esophagus / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D015415:Biomarkers / Q000378:metabolism; D042241:Early Diagnosis; D004945:Esophagoscopy / Q000379:methods; D018662:Fundoplication; D006801:Humans; D011159:Population Surveillance; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment
chemical_list: D015415:Biomarkers; D054328:Proton Pump Inhibitors